Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SmithRx
San Francisco, California, United States
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
SmithRx delivers industry-leading drug savings (average 30%+ reduction), with a transparent business model passing 100% of drug rebates to employers and members; has implemented drug programs such as offering the Humira biosimilar YUSIMRY at a fraction of legacy prices.
- Therapeutic areas
- OncologyImmunologyDermatologyGastroenterology
- Modalities
- Small MoleculeBiologic
- Industry
- Biomedical IT and Biomedical Data Platforms
02
Partnerships
Mark Cuban Cost Plus Drug CompanyCoherus Biosciences
Beyond the preview
Go deeper on SmithRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SmithRx.